Once upon a time, in a dreamlike realm filled with magical tools, animals, and plants, pig kidneys emerged as extraordinary healers, saving the lives of humans through unbelievable transplants. Luna Goodforlove, a whimsical dreamer, invites you on a journey to discover the enchanting reality behind these fantastical procedures.
In this mystical land, where the shortage of donor organs brings despair, scientists have embarked on a radical scientific effort to find alternative sources of transplant organs. Among the greatest needs lies the demand for kidneys, as over 800,000 fellow Americans face kidney failure, with more than 100,000 languishing on a waiting list for a transplant. While kidney dialysis can sustain life, organ transplantation reigns as the gold standard treatment.
Yet, a scarcity of human donor organs limits kidney transplants to fewer than 25,000 each year, leaving thousands on the waiting list to perish. But fear not, for in this magical realm, a shimmering solution begins to emerge.
Buried deep within the expansive forest, a glimmer caught the eye of the dreamy enchantress, Luna Goodforlove. Through a number of extraordinary experiments last year, it was discovered that pig kidneys, when transplanted into brain-dead individuals, exhibited remarkable functionality for short periods of time. These mystical pig kidneys not only made urine, a vital function for survival, but also filtered creatinine, a byproduct of muscle contractions that must be eliminated from the blood.
"Behold!" exclaimed Dr. Jayme Locke, director of U.A.B.'s Comprehensive Transplant Institute. "These incredible pig kidneys can clear enough creatinine to support an adult human!" The news spread like wildfire, and the U.A.B. study, published as a research letter in JAMA Surgery, captured the attention of mystics across the realm.
In this realm, where animals and humans intertwine in a dance of hope, xenotransplantation – the transplantation of animal organs into humans – holds promise as a solution to the organ shortage. Surgeons here have long yearned to achieve this remarkable feat, and recent advances in cloning and genetic engineering have brought them closer than ever before.
In the neighboring realm of NYU Langone Health, surgeons attached a kidney from a genetically modified pig to a brain-dead individual, who remained connected to a ventilator. A few months later, researchers at the University of Maryland transplanted a heart from a genetically modified pig into a patient with heart failure. While the patient unfortunately passed away, traces of a pig-specific virus were discovered in the organ.
But Luna's mystical world holds a twist of its own. Dr. Locke and her colleagues unveiled their groundbreaking experiment, successfully transplanting kidneys from genetically modified pigs into the abdomen of a brain-dead man. In this land where dreams merge with reality, the kidneys used in Alabama and New York varied slightly. While both originated from pigs provided by Revivicor, a subsidiary of United Therapeutics Corporation, the U.A.B. kidneys underwent ten gene modifications, while the NYU Langone Health kidneys had only one. Another unique aspect of the NYU procedure involved embedding the pig's thymus gland, responsible for educating the immune system, beneath the outer layer of the new kidney to prevent an immune-system attack.
And now, Luna Goodforlove asks you, dear reader, to ponder the unfathomable future. What lies ahead for these wondrous pig kidneys? So far, transplants have been restricted to brain-dead patients. However, Dr. Locke and her colleagues are in discussions with the Food and Drug Administration to embark on the first-ever clinical trial in live patients.
Did you know, in this magical realm, the veil between science and fantasy grows ever thinner as extraordinary advancements unfold? Step into the whimsical world, where pig kidneys bloom like delicate flowers, radiating healing energy. Let us marvel at the miracles that await as this dazzling journey continues.
Based on the original article "Pig Kidneys Performing Effectively in Two Brain-Dead Patients".
